Disc Medicine, Inc. (IRON)
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Disc Medicine, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 80.12 | 80.37 | 76.40 | 76.59 | 817,338 |
| Nov 13, 2026 | 83.00 | 83.00 | 79.73 | 80.00 | 779,947 |
| Nov 12, 2026 | 86.16 | 87.14 | 82.66 | 83.23 | 761,217 |
| Nov 11, 2026 | 85.24 | 87.51 | 83.50 | 87.08 | 669,028 |
| Nov 10, 2026 | 80.58 | 86.26 | 80.53 | 84.64 | 1,925,578 |
| Nov 9, 2026 | 80.83 | 81.54 | 76.86 | 81.26 | 912,032 |
| Nov 6, 2026 | 78.65 | 79.52 | 77.67 | 78.91 | 717,552 |
| Nov 5, 2026 | 83.00 | 85.00 | 78.31 | 78.47 | 932,690 |
| Nov 4, 2026 | 81.50 | 83.57 | 80.78 | 83.28 | 1,428,090 |
| Nov 3, 2026 | 79.41 | 81.72 | 79.08 | 81.16 | 1,543,756 |
| Nov 2, 2026 | 80.99 | 81.69 | 78.04 | 78.62 | 525,364 |
| Oct 30, 2026 | 82.79 | 83.03 | 78.61 | 80.84 | 684,975 |
| Oct 29, 2026 | 83.51 | 85.00 | 82.22 | 82.84 | 688,358 |
| Oct 28, 2026 | 78.88 | 83.64 | 78.88 | 83.20 | 1,100,516 |
| Oct 27, 2026 | 77.23 | 80.50 | 76.50 | 79.90 | 1,469,726 |
| Oct 26, 2026 | 74.80 | 78.03 | 74.80 | 77.66 | 1,222,038 |
| Oct 23, 2026 | 74.29 | 75.56 | 74.00 | 74.51 | 1,963,100 |
| Oct 22, 2026 | 75.25 | 78.00 | 74.77 | 75.03 | 1,588,206 |
| Oct 21, 2026 | 77.80 | 81.50 | 75.89 | 76.00 | 4,639,550 |
| Oct 20, 2026 | 79.21 | 80.00 | 74.52 | 79.48 | 2,206,622 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Chief Medical Officer | Sale | 16.0K | $1.36M | Nov 10, 2026 | |
| Director | Sale | 266 | $21.3K | Oct 21, 2026 | |
| Director | Sale | 13.8K | $1.11M | Oct 21, 2026 | |
| Director | Sale | 11.5K | $920.2K | Oct 21, 2026 | |
| Director | Sale | 55 | $4.4K | Oct 20, 2026 | |
| Director | Sale | 2.4K | $190.9K | Oct 20, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
FMR LLC · also on 13F· joint filing· may incl. warrants· filed Aug 2026 | 4.9M | 10.7% | 13G |
FMR LLC | 4.8M | 10.5% | 13F |
Access Industries Management, LLC · joint filing· may incl. warrants· filed Oct 2026 | 2.9M | 6.5% | 13D |
AI DMI LLC 10% Owner | 2.8M | 6.2% | FORM 4 |
BlackRock, Inc. | 2.5M | 5.6% | 13F |
RA CAPITAL MANAGEMENT, L.P. | 2.5M | 5.4% | 13F |
RA Capital Management, L.P. · also on 13F· may incl. warrants· filed Jan 2026 | 2.2M | 4.9% | 13G |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Nov 2024 | 1.9M | 4.1% | 13G |
JPMORGAN CHASE & CO | 1.8M | 4.0% | 13F |
WELLINGTON MANAGEMENT GROUP LLP | 1.8M | 3.9% | 13F |
Insiders
- Savage William JacobChief Medical Officer
- Bitterman KevinDirector
- Quisel John DChief Executive Officer
- Yu Jonathan Yen-WenChief Operating Officer
- Khara RahulChief Legal Officer
- Nicholson Donald WilliamDirector
- White William RichardDirector
- GEMAYEL GEORGESDirector
- AHMED NADIMDirector
- Ratcliffe LiamDirector
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company.
Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases.
The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
based on 45.54M shares outstanding
30d Avg
1.67M
60d Avg
1.16M
90d Avg
950.79K
3 insiders reported 28 open-market sales of IRON stock on Form 4 in the 90 days to Nov 17, 2026. Disc Medicine, Inc. (NASDAQ: IRON) traded at $76.59 on Nov 16, 2026, down 4.26% from the previous close of $80.00. 52-week range: $40.00 to $99.50. The company is in the Healthcare sector (Biotechnology).